ArticleThe Journal of clinical investigation2024
F18-FDG PET imaging as a diagnostic tool for immune checkpoint inhibitor-associated acute kidney injury.
Abstract readCase Reports
In one paragraph
Article in The Journal of clinical investigation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- The Immune Checkpoint Inhibitors Journey: From Early Promise to Lasting Impact.Journal of immunotherapy and precision oncology · 2026Review
- Immune checkpoint inhibitor-associated interstitial nephritis: let's move forward addressing the unknowns.Clinical kidney journal · 2026Review
- Immune Checkpoint Inhibitor-Associated Acute Kidney Injury: A Report from the 34th Acute Disease Quality Initiative (ADQI) Consensus Conference.Journal of the American Society of Nephrology : JASN · 2026Article
- The nephrotoxic effects of anti-cancer therapies: consensus report of the 34th Acute Disease Quality Initiative workgroup.Nature reviews. Nephrology · 2026Review
- Immune checkpoint inhibitor-related acute kidney injury: A diagnostic and therapeutic challenge for nephrologists.World journal of nephrology · 2026Review
- F18-FDG PET-CT in immune checkpoint inhibitor-associated acute interstitial nephritis: what is the diagnostic value?Clinical kidney journal · 2026Article
- Radiopharmaceuticals in Renal Imaging: A Comprehensive Review of Current Applications and Future Prospects.ACS omega · 2026Review
- Risk stratification for immune checkpoint inhibitor rechallenge after acute kidney injury: towards a precision medicine framework.Frontiers in immunology · 2026Review
- Immune checkpoint inhibitor-associated acute interstitial nephritis: Pathogenesis and heterogeneity.CytoJournal · 2026Review
- Bibliometric analysis of immune-related acute kidney injury induced by cancer immunotherapy (2000-2025).Naunyn-Schmiedeberg's archives of pharmacology · 2026Review
- Ten tips for an onco-nephrology clinic.Clinical kidney journal · 2025Review
- Update on Acute Tubulointerstitial Nephritis: Clinical Features, Immunologic Insights, and Diagnostic and Treatment Approaches.Kidney international reports · 2025Review
- Noninvasive Diagnosis of Acute Tubulointerstitial Nephritis in Clinical Practice.Journal of the American Society of Nephrology : JASN · 2025Article
- Urgent considerations on renal immune-related adverse events in oncology practice.Frontiers in immunology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
41 authors.
Shruti GuptaDivision of Renal Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Olivia Green-LingrenDivision of Renal Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Sudhir BhimaniyaHarvard Medical School, Boston, Massachusetts, USA.
Aleksandra KrokhmalDepartment of Radiology, Division of Nuclear Medicine and Molecular Imaging, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Heather JaceneHarvard Medical School, Boston, Massachusetts, USA.
Marlies OstermannDepartment of Critical Care & Nephrology, King's College London, Guy's and St. Thomas' Hospital, London, United Kingdom.
Sugama ChickloreKing's College London & Guy's and St. Thomas' PET Centre, London, United Kingdom.
Ben SprangersBiomedical Research Institute, Department of Immunology and Infection, UHasselt, Diepenbeek, Belgium.
Christophe M DerooseNuclear Medicine, University Hospitals Leuven, Leuven, Belgium.
Sandra M HerrmannDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.
Sophia L WellsDivision of Renal Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Sarah A KaunferDivision of Renal Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Jessica L OrtegaDivision of Renal Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Clara García-CarroNephrology Department, San Carlos Clinical University Hospital, Madrid, Spain.
Michael BoldDepartment of Radiology, Division of Nuclear Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Kevin L ChenDepartment of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Meghan E SiseHarvard Medical School, Boston, Massachusetts, USA.
Pedram HeidariDepartment of Radiology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Wai Lun Will PakRenal Service, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York, USA.
Meghan D LeeDepartment of Medicine, Division of Nephrology, and.
Pazit BeckermanInstitute of Nephrology and Hypertension, Sheba Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Hashomer, Tel Aviv, Israel.
Yael EshetDepartment of Nuclear Imaging, Chaim Sheba Medical Center, Ramat Gan, Israel.
Raymond K HsuDivision of Nephrology and.
Miguel Hernandez PampaloniDepartment of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California, USA.
Arash RashidiDivision of Nephrology and Hypertension, University Hospital Cleveland Medical Center, Cleveland, Ohio, USA.
Norbert AvrilDepartment of Radiology, Nuclear Medicine, University Hospitals, Cleveland, Ohio, USA.
Vicki DonleyDivision of Nephrology and Hypertension, University Hospital Cleveland Medical Center, Cleveland, Ohio, USA.
Zain MithaniKatz Family Division of Nephrology and Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA.
Russ KukerDepartment of Radiology, Division of Nuclear Medicine, University of Miami, Miami, Florida, USA.
Muhammad O AwiwiDivision of Diagnostic Imaging, University of Texas Health Science Center at Houston, Houston, Texas, USA.
Mindy X WangDivision of Internal Medicine, Section of Nephrology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Sujal I ShahDepartment of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Michael D WeintraubHarvard Medical School, Boston, Massachusetts, USA.
Heiko SchoderMolecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Raad B ChowdhuryDivision of Renal Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Harish SeethapathyHarvard Medical School, Boston, Massachusetts, USA.
Kerry L ReynoldsHarvard Medical School, Boston, Massachusetts, USA.
Maria Jose SolerVall d'Hebron University Hospital, Vall d'Hebron Institute of Research, CSUR National Unit of Expertise for Complex Glomerular Diseases of Spain, Barcelona, Spain.
Ala AbudayyehDivision of Internal Medicine, Section of Nephrology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Ilya GlezermanRenal Service, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York, USA.
David E LeafDivision of Renal Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Funding
X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4MEnhancing the therapeutic effect of receptor radionuclide therapy in neuroendocrine tumors by somatostatin receptor upregulationK08CA249047 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI HEIDARI, PEDRAM · 2020 to 2024
$1.3MNCI NIH HHS K08 CA249047NCI NIH HHS P30 CA008748
Abstract
PubMed holds no abstract for this paper.
Indexed as
Acute Kidney InjuryFluorodeoxyglucose F18Immune Checkpoint InhibitorsPositron-Emission TomographyHumansFluorodeoxyglucose F18Immune Checkpoint InhibitorsCancer immunotherapyNephrologyOncology
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.